(Approval lapsed) ESTRAMON estradiol 25 microgram/24 hour transdermal patch (Germany)
Section 19A approved medicine
(Approval lapsed) ESTRAMON estradiol 25 microgram/24 hour transdermal patch (Germany)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Expired
Medicines in short supply/unavailable
ESTRADOT 25 estradiol 25 microgram transdermal drug delivery system sachet - ARTG 338056
Indication(s)
Short-term treatment of signs and symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced. In women with intact uteri, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals. Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.
Additional information
Please note: CONTAINS SOYBEAN OIL. The section 19A approved medicine is contraindicated in patients with known hypersensitivity to the active ingredient, soy, peanut or any of the other ingredients listed. Prior to dispensing and administering, healthcare professionals should determine if this product is suitable for the patient.
Images
